IP Library › Granted Patent US 12,257,001
Granted Patent B2
US 12,257,001 · App. 17/157,245 · Granted Mar 25, 2025

Devices and methods for treating a nerve of the nasal cavity using image guidance

Inventors: Vahid Saadat (Atherton, CA); William Jason Fox (San Mateo, CA); Mojgan Saadat (Atherton, CA)
Assignee: Arrinex, Inc.
A61B34/20A61B18/02A61B18/1492A61B2018/00214A61B2018/00327A61B2018/00434A61B2018/00577A61B2018/00982A61B2018/0212A61B2034/2051A61B2034/2065A61B2034/2072
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,257,001
App. No.
17/157,245
Granted
Mar 25, 2025
Kind
B2
Abstract

The invention disclosed here generally relates to devices used to identify the location of a never in order to modify a property of the nerve. Specifically, the invention utilized pre-operative scans of a patient's nasal cavity in order to identify target treatment locations when a nerve to be treated is located. The image of the nasal cavity and target treatment location can be registered with the real time position of the nasal cavity using a surgical navigation system in order to assist in guiding a surgical probe to the target treatment location.

Claims (50)

1. A system for treating a tissue region within a nasal cavity, comprising:

a surgical navigation device; and

a surgical probe comprising an ablation end effector and one or more location sensors that are detectable by the surgical navigation device,

wherein the surgical navigation device is configured to:

indicate a target treatment location of the tissue region on an image of the nasal cavity, and

register the image of the nasal cavity to the nasal cavity to establish a reference frame,

wherein the ablation end effector is configured to be insertable into the nasal cavity and positioned at the target treatment location using a location of the one or more location sensors in the reference frame,

wherein the ablation end effector is configured to ablate the target treatment location when the ablation end effector is determined to be at the target treatment location, and

wherein at least one location sensor of the one or more location sensors is coupled to a handle of the surgical probe.

2. The system of claim 1 , wherein the target treatment location is a surface in the nasal cavity and the surface is defined by (i) a first reference point corresponding to an intersection of a posterior fontanelle and a perpendicular plate of a palatine bone, (ii) a second reference point corresponding to a sphenopalatine foramen, and (iii) a third reference point corresponding to a ridge of an inferior turbinate,

wherein the ablation end effector comprises a planar member,

wherein the one or more location sensors comprise three location sensors on the planar member, and

wherein the surgical navigation device is configured to determine that the ablation end effector is located at the target treatment location by determining that each of the three location sensors are aligned with a respective one of the first reference point, the second reference point, and the third reference point.

3. The system of claim 2 , wherein the surgical navigation device comprises a display configured to provide an indication of the location of each of the three location sensors relative to the first reference point, the second reference point, and the third reference point of the target treatment location.

4. The system of claim 1 , wherein the target treatment location is a surface in the nasal cavity and the surface is defined by (i) a first reference point corresponding to an intersection of a posterior fontanelle and a perpendicular plate of a palatine bone, (ii) a second reference point corresponding to a sphenopalatine foramen, and (iii) a third reference point corresponding to a ridge of an inferior turbinate,

wherein the one or more location sensors comprise three location sensors located on or within an expandable structure of the ablation end effector coupled to a distal end of the surgical probe, and

wherein the ablation end effector is configured to ablate the target treatment location by introducing a cryogenic fluid into the expandable structure such that the expandable structure inflates from a deflated configuration into an expanded configuration against the surface of the target treatment location.

5. The system of claim 4 , wherein the surgical navigation device comprises a display configured to provide an indication of the location of each of the three location sensors relative to the first reference point, the second reference point, and the third reference point of the target treatment location.

6. The system of claim 1 , wherein the image of the nasal cavity is based on a computed tomography scan.

7. The system of claim 1 , wherein the image of the nasal cavity is based on a magnetic resonance imaging scan.

8. The system of claim 1 , wherein the ablation end effector is configured to ablate the target treatment location by at least one thermal therapy selected from a group of thermal therapies consisting of: cryotherapy, cryoneuromodulation, cryomodulation, cryolysis, cryoablation, and thermoablation.

9. The system of claim 1 , wherein the surgical navigation device comprises a sensor tracking system that is configured to track the location of the one or more location sensors based on at least one signal selected from among a group of signals consisting of: an optical signal and an electromagnetic signal.

10. The system of claim 1 , wherein the handle comprises a detent that is configured to removably couple with the at least one location sensor.

11. The system of claim 1 , wherein the at least one location sensor is coupled a distal end of the handle that is configured to remain outside of the nasal cavity when the ablation end effector ablates the target treatment location.

12. The system of claim 1 , wherein the at least one location sensor is located at an internal portion of the handle.

13. The system of claim 1 , wherein the ablation end effector comprises a plurality of electrodes that are configured to a radiofrequency energy to ablate the target treatment location.

14. The system of claim 13 , wherein, for each electrode, a respective location sensor of the one or more location sensors is located proximate to the electrode.

15. The system of claim 1 , wherein the surgical navigation device is configured to determine the target treatment location using image recognition software.

16. A system for treating a tissue region within a nasal cavity, comprising:

a surgical navigation device; and

a surgical probe comprising an ablation end effector and one or more location sensors that are detectable by the surgical navigation device,

wherein the surgical navigation device is configured to:

indicate a target treatment location of the tissue region on an image of the nasal cavity, and

register the image of the nasal cavity to the nasal cavity to establish a reference frame,

wherein the ablation end effector is configured to be insertable into the nasal cavity and positioned at the target treatment location using a location of the one or more location sensors in the reference frame,

wherein the ablation end effector is configured to ablate the target treatment location when the ablation end effector is determined to be at the target treatment location, and

wherein indicating the target treatment location comprises identifying a sphenopalatine foramen in the image of the nasal cavity.

17. The system of claim 16 , wherein surgical navigation device is configured to determine the target treatment location by measuring a predetermined distance from the sphenopalatine foramen in the reference frame.

18. The system of claim 17 , wherein surgical navigation device is configured to determine the target treatment location by measuring a predetermined direction from the sphenopalatine foramen in the reference frame.

19. A system for treating a tissue region within a nasal cavity, comprising:

a surgical navigation device; and

a surgical probe comprising an ablation end effector and one or more location sensors that are detectable by the surgical navigation device,

wherein the surgical navigation device is configured to:

indicate a target treatment location of the tissue region on an image of the nasal cavity, and

register the image of the nasal cavity to the nasal cavity to establish a reference frame,

wherein the ablation end effector is configured to be insertable into the nasal cavity and positioned at the target treatment location using a location of the one or more location sensors in the reference frame,

wherein the ablation end effector is configured to ablate the target treatment location when the ablation end effector is determined to be at the target treatment location,

wherein the surgical navigation device further comprises a localizer frame that is configured to be worn by a patient, and

wherein the localizer frame comprises at least a portion of the one or more location sensors.

20. The system of claim 19 , wherein the ablation end effector is configured to ablate the target treatment location by at least one thermal therapy selected from a group of thermal therapies consisting of: cryotherapy, cryoneuromodulation, cryomodulation, cryolysis, cryoablation, and thermoablation.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 22, 2026
From: ARRINEX, INC,
To: STRYKER CORPORATION
Reel/Frame 076101/0884 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 3, 2021
From: SAADAT, VAHID; FOX, WILLIAM JASON; SAADAT, MOJGAN
To: ARRINEX, INC.
Reel/Frame 055135/0479 →
Continuity (3)
Division 15655832 · Jul 20, 2017
Provisional Application 62364753 · Jul 20, 2016
Related Publication 20210137610A1 · May 13, 2021
References Cited (248)
US 1604554A · Wise et al. · 1898 [cited by applicant]
US 5971979A · Joye et al. · 1999 [cited by applicant]
US 6064905A · Webster, Jr. · 2000 [cited by examiner]
US 6283959B1 · Lalonde et al. · 2001 [cited by applicant]
US 6355029B1 · Joye et al. · 2002 [cited by applicant]
US 6375654B1 · McIntyre · 2002 [cited by applicant]
US 6428534B1 · Joye et al. · 2002 [cited by applicant]
US 6432102B2 · Joye et al. · 2002 [cited by applicant]
US 6514245B1 · Williams et al. · 2003 [cited by applicant]
US 6517533B1 · Swaminathan · 2003 [cited by applicant]
US 6537271B1 · Murray et al. · 2003 [cited by applicant]
US 6575966B2 · Lane et al. · 2003 [cited by applicant]
US 6595988B2 · Wittenberger et al. · 2003 [cited by applicant]
US 6602276B2 · Dobak, III et al. · 2003 [cited by applicant]
US 6648879B2 · Joye et al. · 2003 [cited by applicant]
US 6666858B2 · Lafontaine · 2003 [cited by applicant]
US 6673066B2 · Werneth · 2004 [cited by applicant]
US 6685732B2 · Kramer · 2004 [cited by applicant]
US 6736809B2 · Capuano et al. · 2004 [cited by applicant]
US 6786900B2 · Joye et al. · 2004 [cited by applicant]
US 6786901B2 · Joye et al. · 2004 [cited by applicant]
US 6811550B2 · Holland et al. · 2004 [cited by applicant]
US 6875209B2 · Zvuloni et al. · 2005 [cited by applicant]
US 6905494B2 · Yon et al. · 2005 [cited by applicant]
US 6908462B2 · Joye et al. · 2005 [cited by applicant]
US 6949096B2 · Davison et al. · 2005 [cited by applicant]
US 6972015B2 · Joye et al. · 2005 [cited by applicant]
US 6989009B2 · Lafontaine · 2006 [cited by applicant]
US 6991631B2 · Woloszko et al. · 2006 [cited by applicant]
US 7001378B2 · Yon et al. · 2006 [cited by applicant]
US 7060062B2 · Joye et al. · 2006 [cited by applicant]
US 7081112B2 · Joye et al. · 2006 [cited by applicant]
US 7101368B2 · Lafontaine · 2006 [cited by applicant]
US 7189227B2 · Lafontaine · 2007 [cited by applicant]
US 7288089B2 · Yon et al. · 2007 [cited by applicant]
US 7291144B2 · Dobak, III et al. · 2007 [cited by applicant]
US 7300433B2 · Lane et al. · 2007 [cited by applicant]
US 7354434B2 · Zvuloni et al. · 2008 [cited by applicant]
US 7442190B2 · Abboud et al. · 2008 [cited by applicant]
US 7449018B2 · Kramer · 2008 [cited by applicant]
US 7527622B2 · Lane et al. · 2009 [cited by applicant]
US 7641679B2 · Joye et al. · 2010 [cited by applicant]
US 7648497B2 · Lane et al. · 2010 [cited by applicant]
US 7720521B2 · Chang · 2010 [cited by examiner]
US 7727191B2 · Mihalik et al. · 2010 [cited by applicant]
US 7727228B2 · Abboud et al. · 2010 [cited by applicant]
US 7740627B2 · Gammie et al. · 2010 [cited by applicant]
US 7771409B2 · Chang · 2010 [cited by examiner]
US 7794455B2 · Abboud et al. · 2010 [cited by applicant]
US 7842031B2 · Abboud et al. · 2010 [cited by applicant]
US 7862557B2 · Joye et al. · 2011 [cited by applicant]
US 7892230B2 · Woloszko · 2011 [cited by applicant]
US 8043283B2 · Dobak, III et al. · 2011 [cited by applicant]
US 8043351B2 · Yon et al. · 2011 [cited by applicant]
US 8157794B2 · Dobak, III et al. · 2012 [cited by applicant]
US 8172828B2 · Chang · 2012 [cited by examiner]
US 8177779B2 · Joye et al. · 2012 [cited by applicant]
US 8187261B2 · Watson · 2012 [cited by applicant]
US 8235976B2 · Lafontaine · 2012 [cited by applicant]
US 8292887B2 · Woloszko et al. · 2012 [cited by applicant]
US 8298217B2 · Lane et al. · 2012 [cited by applicant]
US 8333758B2 · Joye et al. · 2012 [cited by applicant]
US 8382747B2 · Abboud et al. · 2013 [cited by applicant]
US 8425456B2 · Wihalik et al. · 2013 [cited by applicant]
US 8439906B2 · Watson · 2013 [cited by applicant]
US 8465481B2 · Mazzone et al. · 2013 [cited by applicant]
US 8475440B2 · Abboud et al. · 2013 [cited by applicant]
US 8480664B2 · Watson et al. · 2013 [cited by applicant]
US 8491636B2 · Abboud et al. · 2013 [cited by applicant]
US 8512324B2 · Abboud et al. · 2013 [cited by applicant]
US 8545491B2 · Abboud et al. · 2013 [cited by applicant]
US 8591504B2 · Tin · 2013 [cited by applicant]
US 8617149B2 · Lafontaine et al. · 2013 [cited by applicant]
US 8632529B2 · Bencini · 2014 [cited by applicant]
US 8663211B2 · Fourkas et al. · 2014 [cited by applicant]
US 8672930B2 · Wittenberger · 2014 [cited by applicant]
US 8679104B2 · Abboud et al. · 2014 [cited by applicant]
US 8679105B2 · Wittenberger et al. · 2014 [cited by applicant]
US 8715274B2 · Watson · 2014 [cited by applicant]
US 8747401B2 · Gonzalez et al. · 2014 [cited by applicant]
US 8764740B2 · Watson · 2014 [cited by applicant]
US 8771264B2 · Abboud et al. · 2014 [cited by applicant]
US 8827952B2 · Subramaniam et al. · 2014 [cited by applicant]
US 8900222B2 · Abboud et al. · 2014 [cited by applicant]
US 8911434B2 · Wittenberger · 2014 [cited by applicant]
US 8926602B2 · Pageard · 2015 [cited by applicant]
US 8936594B2 · Wolf · 2015 [cited by applicant]
US 8945107B2 · Buckley et al. · 2015 [cited by applicant]
US 8986293B2 · Desrochers · 2015 [cited by applicant]
US 8986301B2 · Wolf et al. · 2015 [cited by applicant]
US 9050074B2 · Joye et al. · 2015 [cited by applicant]
US 9060754B2 · Buckley et al. · 2015 [cited by applicant]
US 9060755B2 · Buckley et al. · 2015 [cited by applicant]
US 9066713B2 · Turovskiy · 2015 [cited by applicant]
US 9072597B2 · Wolf et al. · 2015 [cited by applicant]
US 9084590B2 · Wittenberger et al. · 2015 [cited by applicant]
US 9084592B2 · Wu et al. · 2015 [cited by applicant]
US 9089314B2 · Wittenberger · 2015 [cited by applicant]
US 9168079B2 · Lalonde · 2015 [cited by applicant]
US 9179964B2 · Wolf et al. · 2015 [cited by applicant]
US 9179967B2 · Wolf et al. · 2015 [cited by applicant]
US 9211393B2 · Hu et al. · 2015 [cited by applicant]
US 9220556B2 · Lalonde et al. · 2015 [cited by applicant]
US 9237924B2 · Wolf et al. · 2016 [cited by applicant]
US 9241752B2 · Nash et al. · 2016 [cited by applicant]
US 9254166B2 · Aluru et al. · 2016 [cited by applicant]
US 9333023B2 · Wittenaberger · 2016 [cited by applicant]
US 9414878B1 · Wu et al. · 2016 [cited by applicant]
US 9415194B2 · Wolf et al. · 2016 [cited by applicant]
US 9433463B2 · Wolf et al. · 2016 [cited by applicant]
US 9439709B2 · Duong et al. · 2016 [cited by applicant]
US 9445859B2 · Pageard · 2016 [cited by applicant]
US 9452010B2 · Wolf et al. · 2016 [cited by applicant]
US 9480521B2 · Kim et al. · 2016 [cited by applicant]
US 9486278B2 · Wolf et al. · 2016 [cited by applicant]
US 9522030B2 · Harmouche et al. · 2016 [cited by applicant]
US 9526571B2 · Wolf et al. · 2016 [cited by applicant]
US 9555223B2 · Abboud et al. · 2017 [cited by applicant]
US 9572536B2 · Abboud et al. · 2017 [cited by applicant]
US 9763743B2 · Lin · 2017 [cited by examiner]
US 9801752B2 · Scott et al. · 2017 [cited by applicant]
US 10092355B1 · Hannaford · 2018 [cited by examiner]
US 20030144659A1 · Edwards et al. · 2003 [cited by applicant]
US 20080009851A1 · Wittenberger et al. · 2008 [cited by applicant]
US 20080009925A1 · Abboud et al. · 2008 [cited by applicant]
US 20080027423A1 · Choi et al. · 2008 [cited by applicant]
US 20090182318A1 · Abboud et al. · 2009 [cited by applicant]
US 20090234345A1 · Hon · 2009 [cited by applicant]
US 20120029493A1 · Wittenberger et al. · 2012 [cited by applicant]
US 20130218151A1 · Mihalik et al. · 2013 [cited by applicant]
US 20140058369A1 · Hon · 2014 [cited by applicant]
US 20140207130A1 · Fourkas et al. · 2014 [cited by applicant]
US 20150045781A1 · Abboud et al. · 2015 [cited by applicant]
US 20150119868A1 · Lalonde et al. · 2015 [cited by applicant]
US 20150157382A1 · Avitall et al. · 2015 [cited by applicant]
US 20150164571A1 · Saadat · 2015 [cited by applicant]
US 20150190188A1 · Lalonde et al. · 2015 [cited by applicant]
US 20150196740A1 · Mallin et al. · 2015 [cited by applicant]
US 20150223860A1 · Wittenberger et al. · 2015 [cited by applicant]
US 20150250524A1 · Moriarty et al. · 2015 [cited by applicant]
US 20150265329A1 · Lalonde et al. · 2015 [cited by applicant]
US 20150265812A1 · Lalonde · 2015 [cited by applicant]
US 20160038212A1 · Ryba et al. · 2016 [cited by applicant]
US 20160045277A1 · Lin et al. · 2016 [cited by applicant]
US 20160066975A1 · Fourkas et al. · 2016 [cited by applicant]
US 20160074090A1 · Lalonde et al. · 2016 [cited by applicant]
US 20160143683A1 · Aluru et al. · 2016 [cited by applicant]
US 20160166305A1 · Nash et al. · 2016 [cited by applicant]
US 20160166306A1 · Pageard · 2016 [cited by applicant]
US 20160220295A1 · Wittenberger · 2016 [cited by applicant]
US 20160287315A1 · Wolf et al. · 2016 [cited by applicant]
US 20160331433A1 · Wu et al. · 2016 [cited by applicant]
US 20160331459A1 · Townley et al. · 2016 [cited by applicant]
US 20160354134A1 · Pageard · 2016 [cited by applicant]
US 20160354135A1 · Saadat · 2016 [cited by applicant]
US 20160354136A1 · Saadat · 2016 [cited by applicant]
US 20160361112A1 · Wolf et al. · 2016 [cited by applicant]
US 20170007316A1 · Wolf et al. · 2017 [cited by applicant]
US 20170014258A1 · Wolf et al. · 2017 [cited by applicant]
US 20170042601A1 · Kim et al. · 2017 [cited by applicant]
US 20170056087A1 · Buckley et al. · 2017 [cited by applicant]
US 20170056632A1 · Jenkins et al. · 2017 [cited by applicant]
WO 99020185 · 1999 [cited by applicant]
WO 9927862 · 1999 [cited by applicant]
WO 99030655 · 1999 [cited by applicant]
WO 0009053 · 2000 [cited by applicant]
WO 0047118 · 2000 [cited by applicant]
WO 0054684 · 2000 [cited by applicant]
WO 0164145 · 2001 [cited by applicant]
WO 01095819 · 2001 [cited by applicant]
WO 0204042 · 2002 [cited by applicant]
WO 0207628 · 2002 [cited by applicant]
WO 02069862 · 2002 [cited by applicant]
WO 0200128 · 2002 [cited by applicant]
WO 02083196 · 2003 [cited by applicant]
WO 03013653 · 2003 [cited by applicant]
WO 03026719 · 2003 [cited by applicant]
WO 03051214 · 2003 [cited by applicant]
WO 03028524 · 2003 [cited by applicant]
WO 03020334 · 2003 [cited by applicant]
WO 03088857 · 2003 [cited by applicant]
WO 2004000092 · 2003 [cited by applicant]
WO 2005089853 · 2005 [cited by applicant]
WO 2004108207 · 2005 [cited by applicant]
WO 2006002337 · 2006 [cited by applicant]
WO 2006118725 · 2006 [cited by applicant]
WO 2006119615 · 2006 [cited by applicant]
WO 2006124176 · 2006 [cited by applicant]
WO 2006017073 · 2007 [cited by applicant]
WO 2007145759 · 2007 [cited by applicant]
WO 2008000065 · 2008 [cited by applicant]
WO 2008042890 · 2008 [cited by applicant]
WO 2008046183 · 2008 [cited by applicant]
WO 2008157042 · 2008 [cited by applicant]
WO 2009114701 · 2009 [cited by applicant]
WO 2009146372 · 2009 [cited by applicant]
WO 2010081221 · 2010 [cited by applicant]
WO 2010083281 · 2010 [cited by applicant]
WO 2010111122 · 2010 [cited by applicant]
WO 2011014812 · 2011 [cited by applicant]
WO 2011091507 · 2011 [cited by applicant]
WO 2011091508 · 2011 [cited by applicant]
WO 2011091509 · 2011 [cited by applicant]
WO 2011091533 · 2011 [cited by applicant]
WO 2012012868 · 2012 [cited by applicant]
WO 2012012869 · 2012 [cited by applicant]
WO 2012015636 · 2012 [cited by applicant]
WO 2012019156 · 2012 [cited by applicant]
WO 2012051697 · 2012 [cited by applicant]
WO 2012027641 · 2012 [cited by applicant]
WO 2012058156 · 2012 [cited by applicant]
WO 2012058159 · 2012 [cited by applicant]
WO 2012058160 · 2012 [cited by applicant]
WO 2012058161 · 2012 [cited by applicant]
WO 2012058165 · 2012 [cited by applicant]
WO 2012058167 · 2012 [cited by applicant]
WO 2012174161 · 2012 [cited by applicant]
WO 2013110156 · 2013 [cited by applicant]
WO 2013163325 · 2014 [cited by applicant]
WO 2014113864 · 2014 [cited by applicant]
WO 2014138866 · 2014 [cited by applicant]
WO 2014138867 · 2014 [cited by applicant]
WO 2015038523 · 2015 [cited by applicant]
WO 2015048806 · 2015 [cited by applicant]
WO 2015061883 · 2015 [cited by applicant]
WO 2015081420 · 2015 [cited by applicant]
WO 2015106335 · 2015 [cited by applicant]
WO 2015114038 · 2015 [cited by applicant]
WO 2015139117 · 2015 [cited by applicant]
WO 2015139118 · 2015 [cited by applicant]
WO 2015153696 · 2015 [cited by applicant]
WO 2016183337 · 2016 [cited by applicant]
WO 2016186964 · 2016 [cited by applicant]
WO 2017034705 · 2017 [cited by applicant]
WO 2017047543 · 2017 [cited by applicant]
WO 2017047545 · 2017 [cited by applicant]
Bicknell et al., “Cryosurgery for Allergic and Vasomotor Rhinitis”, The Journal of Laryngology and Otology, vol. 93, Feb. 1979, 143-146. [cited by applicant]
Bluestone et al., “Instranasal Freezing for Severe Epistaxis”, Arch Otolaryngol. 85, Apr. 1967, 199-121. [cited by applicant]
Bumsted, “Cryotherapy for Chronic Vasomotor Rhinitis: Technique and Patient Selection for Improved Results”, Laryngoscope, vol. 94, Apr. 1984, pp. 539-544. [cited by applicant]
Costa et al., “radiographic and Anatomic Characterization of the Nasal Septal Swell Body”, Arch Otolaryngol Head Neck Surg., vol. 136, No. 11, Nov. 2010, 1109. [cited by applicant]
Girdhar-Gopal, “An Assessment of Postganglionic Cryoneurolysls for Managing Vasomotor Rhinitis”, American Journal of Rhinology, vol. 8, No. 4 Jul.-Aug. 1994, pp. 157-164. [cited by applicant]
Golhar et al., “The Effect of Cryodestruction of Vidian Nasal Branches on Nasal Mucus Flow in Vasomotor Rhinitis”, Indian Journal of of Otolaryngology, vol. 33, No. 1, Mar. 1981, pp. 12-14. [cited by applicant]
Hadoura et al., Mapping Surgical Coordinates of the Sphenopalatine Foramen: Surgical Navigation Study, The Journal of Laryngology and Otology, 123, pp. 742-745. [cited by applicant]
Ozenberger, “Cryosurgery in Chronic Rhinitis”, The Laryngoscope, vol. 80, No. 5, May 1970, pp. 723-734. [cited by applicant]
Principato, “Chronic Vaomotor Rhinitis: Cryogenic and Other Surgical Modes of Treatment”, The Laryngoscope, vol. 89, 1979, pp. 619-638. [cited by applicant]
Sanu, “Two Hundred Years of Controversy Between UK and USA”, Rhinology, 86-91. [cited by applicant]
Settipane et al., “Update on Non allergic Rhinitis”, Annals of Allergy Asthma & Immunology, vol. 86, 2001 494-508. [cited by applicant]
Terao et al., “Cryosurgery on Postganglionic Fibers (Posterior Nasal Branches) Of The Pterygopalatine Ganglion for Vasomotor Rhinitis”, Acta Otolaryngol., vol. 96, 1983, pp. 139-148. [cited by applicant]